Abstract
Citation: Dattola A, Zangrilli A, Bianchi L. Risankizumab for plaque and guttate psoriasis in a patient with IgA -related glomerulonephritis. Dermatol Pract Concept. 2021;11(4):e2021100. DOI: https://doi.org/10.5826/dpc.1104a100 Accepted: March 8, 2021; Published: October, 2021 Copyright: ©2021 Dattola et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Annunziata Dattola, Department of Dermatology, Policlinico Tor Vergata, Rome, Italy. Email: nancydattola@gmail.com Keywords : guttate psoriasis, plaque psoriasis, risankizumab, renal disease This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.